Absci (ABSI) Deferred Taxes (2021 - 2024)
Absci (ABSI) posted Deferred Taxes of -$11000.0 for Q1 2024, up 82.54% sequentially from -$63000.0 in Q4 2023, and up 21.43% YoY from -$9058.8 in Q2 2023.
Powered by 
Analysis
Absci (ABSI) Deferred Taxes (2021 - 2024) Analysis & Trends
Absci has reported Deferred Taxes for 4 years, with the latest figure at -$11000.0 in Q1 2024.
- Quarterly Deferred Taxes rose 21.43% year-over-year to -$11000.0 in Q1 2024, while the trailing twelve-month figure through Jun 2024 was -$48000.0 (up 94.43% YoY) and the FY2023 annual result came in at -$52000.0, up 89.7% from the prior year.
- Deferred Taxes climbed to -$11000.0 in Q1 2024 per ABSI's latest filing, from -$63000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $616000.0 in Q1 2022 and troughed at -$5.6 million in Q2 2021.
- A 4-year average of -$728384.6 and a median of -$274000.0 in 2022 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2022 and 2023: Deferred Taxes soared 229.14% in 2022, then slumped 102.27% in 2023.
- Over 4 years, Deferred Taxes stood at -$1.1 million in 2021, then jumped by 53.08% to -$518000.0 in 2022, then jumped by 87.84% to -$63000.0 in 2023, then soared by 82.54% to -$11000.0 in 2024.
- According to Business Quant data, Deferred Taxes over the past three periods registered -$11000.0, -$63000.0, and $26000.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Absci | 1.39 Bn | 1.19 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | -63,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | -518,000.00 |
| Sep 30, 2022 | -329,000.00 |
| Jun 30, 2022 | -274,000.00 |
| Mar 31, 2022 | 616,000.00 |
| Dec 31, 2021 | -1.10 Mn |
| Sep 30, 2021 | -1.70 Mn |
| Jun 30, 2021 | -5.62 Mn |
| Mar 31, 2021 | -477,000.00 |